The Europe clinical trial management market growth is expected to progress at a CAGR of 13.00% during the forecast period, 2022-2030. The high number of clinical trials conducted, the availability of trained professionals, and the growing demand for novel drugs for chronic disease treatment propel market growth.

EUROPE CLINICAL TRIAL MANAGEMENT MARKET FORECAST 2022-2030

Europe Clinical Trial Management Market by End-user (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers) Market by Product Type (Enterprise-based CTM, Site-based CTM) Market by Deployment Model (Web-based Deployment, on-premise Deployment, Cloud-based Deployment) Market by Component (Software, Hardware, Services) by Geography

Request free sample

Report Summary

europe-clinical-trial-management-market

To learn more about this report, request a free sample copy

The Europe clinical trial management market growth assessment includes the analysis of the United Kingdom, Sweden, Hungary, Spain, Denmark, Germany, France, Italy, Russia, and Rest of Europe. The United Kingdom has a leading genomics industry, including research in genetics, biochemical, and human DNA. The government efforts in integrating genomics with healthcare have benefited biotech companies. For instance, the NHS has launched a genomic medicine service set to include human genomics data into standard healthcare. Further, commercial clinical research trends have been stable in recent years. The UK falls short in terms of Phase III clinical trials in comparison to other European countries. As a result, the government has extended its support to the launch of ‘High Throughput Centers’ to propel Phase II and III trials. Such developments promote market growth in the UK.

France is one of the complex markets with regard to the commercialization of pharmaceutical products. It has the highest consumption of medicines per capita globally. It is also the second-largest market in Europe for medical care. In 2016, the country announced the development of a large-scale genome sequencing operation in healthcare. Such factors are projected to contribute to the France market growth.

Bioclinica is an integrated clinical life science solutions provider. It delivers insights into clinical trial development. The company also offers clinical adjudication, trial supply management & optimization, clinical trial management software, etc. It has an extensive global presence and a strong product portfolio in the clinical trial management system. It is headquartered in Princeton, New Jersey, United States.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
MARKET DYNAMICS
- PARENT MARKET ANALYSIS – HEALTHCARE
- MARKET SCOPE
- KEY DRIVERS
  - OUTSOURCING OF CLINICAL TRIALS
  - GROWING NUMBER OF CLINICAL TRIALS
  - AWARENESS REGARDING THE BENEFITS OF USING CTM SOFTWARE
  - INCIDENCES OF CHRONIC DISEASES
  - RESEARCH & DEVELOPMENT
- KEY RESTRAINTS
  - SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
  - COST OF IMPLEMENTATION
  - SECURITY CONCERNS

KEY ANALYTICS
- IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
  - BUYERS POWER
  - SUPPLIERS POWER
  - SUBSTITUTION
  - NEW ENTRANTS
  - INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
MARKET BY END-USER
- PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
- CLINICAL RESEARCH ORGANIZATIONS
- HEALTHCARE PROVIDERS
MARKET BY PRODUCT TYPE
- ENTERPRISE-BASED CTM
- SITE-BASED CTM
MARKET BY DEPLOYMENT MODEL
- WEB-BASED DEPLOYMENT
- ON-PREMISE DEPLOYMENT
- CLOUD-BASED DEPLOYMENT
MARKET BY COMPONENT
- SOFTWARE
- HARDWARE
- SERVICES
GEOGRAPHICAL ANALYSIS
- EUROPE
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - UNITED KINGDOM
    - GERMANY
    - FRANCE
    - ITALY
    - RUSSIA
    - DENMARK
    - HUNGARY
    - SWEDEN
    - SPAIN
    - REST OF EUROPE

COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
  - MERGERS & ACQUISITIONS
  - PRODUCT LAUNCHES & DEVELOPMENTS
  - PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
- COMPANY PROFILES
  - ADVARRA (FORTE RESEARCH SYSTEMS INC)
  - ARISGLOBAL LLC
  - BIOCLINICA INC
  - BIO-OPTRONICS INC
  - IBM CORPORATION
  - MEDIDATA SOLUTIONS INC
  - MEDNET SOLUTIONS INC
  - ORACLE CORPORATION
  - PAREXEL INTERNATIONAL CORPORATION
  - VEEVA SYSTEMS INC

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – CLINICAL TRIAL MANAGEMENT

TABLE 2: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 3: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 4: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 5: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 6: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 7: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 8: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 9: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 10: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 11: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 12: KEY PLAYERS OPERATING IN EUROPE CLINICAL TRIAL MANAGEMENT MARKET

TABLE 13: LIST OF MERGERS & ACQUISITIONS

TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 15: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

FIGURE 6: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)

FIGURE 7: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2022-2030 (IN $ MILLION)

FIGURE 8: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2022-2030 (IN $ MILLION)

FIGURE 9: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021

FIGURE 10: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2022-2030 (IN $ MILLION)

FIGURE 11: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2022-2030 (IN $ MILLION)

FIGURE 12: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2021

FIGURE 13: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)

FIGURE 14: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2022-2030 (IN $ MILLION)

FIGURE 15: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)

FIGURE 16: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2021

FIGURE 17: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2022-2030 (IN $ MILLION)

FIGURE 18: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2022-2030 (IN $ MILLION)

FIGURE 19: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)

FIGURE 20: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 21: UNITED KINGDOM CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 22: GERMANY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 23: FRANCE CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 24: ITALY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 25: RUSSIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 26: DENMARK CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 27: HUNGARY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 28: SWEDEN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 29: SPAIN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

FIGURE 30: REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- EUROPE
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - UNITED KINGDOM
    - GERMANY
    - FRANCE
    - ITALY
    - RUSSIA
    - DENMARK
    - HUNGARY
    - SWEDEN
    - SPAIN
    - REST OF EUROPE

MARKET BY END-USER
- PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
- CLINICAL RESEARCH ORGANIZATIONS
- HEALTHCARE PROVIDERS
MARKET BY PRODUCT TYPE
- ENTERPRISE-BASED CTM
- SITE-BASED CTM
MARKET BY DEPLOYMENT MODEL
- WEB-BASED DEPLOYMENT
- ON-PREMISE DEPLOYMENT
- CLOUD-BASED DEPLOYMENT
MARKET BY COMPONENT
- SOFTWARE
- HARDWARE
- SERVICES